Brain Tumor Basic Science Faculty Position
The Department of Neurosurgery and the Huntsman Cancer Institute are seeking an exceptional Basic Science/Early Translational candidate with a focused interest in brain tumors to join our Faculty at the Assistant or Associate Professor level (tenure track). The selected individual will be an accomplished academic with a track record of significant research funding, and with a history of successful collaboration. Their scientific program will be housed within HCI, and will provide the opportunity to conduct collaborative work among the neuro-oncology community at HCI and the University of Utah, in concert with the clinician scientists within the large department of Neurosurgery. These combined entities offer a robust research environment, and the candidate will be expected to demonstrate a strong commitment to national and international collaborative research and to initiate and help facilitate in interdisciplinary projects within our Center for Neurologic Cancers.
The Center for Neurologic Cancers is part of the Huntsman Cancer Institute at the University of Utah Health Sciences Center, which is an NCI-designated Comprehensive Cancer Center and a member of the National Comprehensive Cancer Network (NCCN), supporting and fostering a vibrant research enterprise in a highly collegial environment. HCI has a strong history of academic achievement and impact as well as a commitment to excellence in patient care, research, teaching and service. HCI is undergoing a major expansion which includes new research and clinical buildings. We are seeking a junior or mid-career investigator with innovative basic or translational cancer biology programs that emphasize mechanistic approaches to the understanding and treatment of primary and/or metastatic brain tumors. Areas of interest include signal transduction, stem cells, gene regulation/transcription, chromatin/epigenetics, genome stability/DNA repair, cancer metabolism, cancer genetics, metastasis, tumor immunology, pediatric/youth cancers, target validation, drug discovery/validation, epigenetics & gene expression, DNA damage & repair, cancer initiating cells, and mechanisms of therapy resistance.
HCI and the University Health Sciences Center provide access to state-of-the-art equipment and services through exceptional Core Facilities (see www.cores.utah.edu) that enhance both discovery and translational science. HCI also offers state-of-the-art laboratories, including a new 225,000 sq. ft. research building which doubles its research space, and opened summer 2017. The University of Utah offers robust graduate programs for training PhD and MD/PhD students. For more information about HCI, visit www.huntsmancancer.org.